Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) [Phase 2]
Phase 2 trial update for TAS-102 (Lonsurf) in metastatic or locally advanced unresectable pancreatic adenocarcinoma after first-line therapy…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial investigating short-course radiation therapy with proton or photon beam, capecitabine, and hydroxychloroquine for resectable p…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer [Phase 2]
Phase 2 study evaluating nab-paclitaxel plus S-1 as first-line therapy for advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: The Transformation of Locally Advanced Pancreatic Cancer. [Phase 2]
Phase 2 clinical trial update for locally advanced pancreatic cancer, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer [Phase 2]
Phase II trial update for Anetumab Ravtansine in pre-treated mesothelin-expressing pancreatic cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer [Phase 2]
Phase 2 trial update studying nal-IRI combined with S1 as second-line therapy for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating nab-paclitaxel and gemcitabine hydrochloride followed by radiation therapy prior to surgery in resectable pancreati…
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations [Phase 2]
Phase 2 trial assessing selumetinib sulfate in locally advanced or metastatic pancreatic cancer with KRAS G12R mutations has completed with …
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating capecitabine, temozolomide, and bevacizumab for metastatic or unresectable pancreatic neuroendocrine tumors has com…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer [Phase 1, Phase 2]
An open-label Phase I/II study evaluating a pan-immunotherapy in local advanced/metastatic pancreatic cancer is ongoing; no results or statu…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating Everolimus (RAD001) in combination with Gemcitabine for advanced or metastatic pancreatic adenocarcino…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis [Phase 2]
Phase 2 trial evaluating microwave ablation plus chemotherapy for pancreatic cancer with liver oligometastasis; status and results not provi…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
A Phase 2 trial of antineoplaston therapy in Stage IV pancreatic cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. [NA]
A completed clinical trial comparing back-loaded versus preloaded fiducial needles for EUS-guided fiducial marker placement in pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Masitinib Plus Gemcitabine in Pancreatic Cancer [Phase 3]
Phase 3 trial update for masitinib plus gemcitabine in locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer [Phase 2]
Phase 2 open-label study of CS-1008 for untreated and unresectable pancreatic cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer [Phase 2, Phase 3]
A clinical trial update reports on the efficacy and safety of K-001 for advanced pancreatic cancer in phase 2 and phase 3, with unspecified …
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy [NA]
Clinical trial update on gemcitabine pharmacokinetics after preoperative chemoradiation in pancreatic cancer; study terminated with results …
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of combining irreversible electroporation (IRE) with γδ T cell therapy for loc…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours [Phase 2]
Phase 2 trial update evaluating chemotherapy with additional chemoradiotherapy for locally advanced pancreatic cancer and borderline resecta…
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy and radiation with or without tipifarnib in locally advanced pancreatic cancer has complet…
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating a combination regimen of capecitabine, bevacizumab, and radiation followed by gemcitabine and bevacizumab for local…
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial updating neoadjuvant S-1 with concurrent radiotherapy for borderline resectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies [Phase 3]
Phase 3 trial assessing endoscopic biliary co-axial stent placement with or without radiofrequency ablation for clearing occluded self-expan…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial comparing pegilodecakin with FOLFOX versus FOLFOX alone as second-line therapy in metastatic pancreatic cancer; completed with…